A Preliminary Study of Prophylactic Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea

Trial Profile

A Preliminary Study of Prophylactic Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 29 Aug 2017

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Cancer pain; Dyspnoea
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Aug 2017 Status changed from active, no longer recruiting to recruiting.
    • 09 May 2017 Status changed from recruiting to active, no longer recruiting.
    • 16 Mar 2017 Planned primary completion date changed from 1 Jan 2018 to 1 Jan 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top